We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cancer Drugs, Biologics, Trial Design Are Among Top 2015 Trends in Tufts Annual Outlook Report
Cancer Drugs, Biologics, Trial Design Are Among Top 2015 Trends in Tufts Annual Outlook Report
Drug sponsors are expected to expand their investments in developing new cancer therapies this year, spurred by a growing understanding of tumors’ molecular bases and immunotherapy techniques, according to a new report that projects pharma and biotech trends for 2015.